Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule linéaire :
(CH3)2NH
Numéro CAS:
Poids moléculaire :
45.08
UNSPSC Code:
12352116
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
605257
Concentration:
1.90-2.20 M (by NaOH, titration), 2.0 M in THF
Form:
liquid
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderform
liquid
Quality Level
concentration
1.90-2.20 M (by NaOH, titration), 2.0 M in THF
bp
~60 °C
density
0.85 g/mL at 25 °C
functional group
amine
SMILES string
CNC
InChI
1S/C2H7N/c1-3-2/h3H,1-2H3
InChI key
ROSDSFDQCJNGOL-UHFFFAOYSA-N
Application
Dimethylamine solution (2M in THF) has been used in the synthesis of 2-dimethylamino-1-(3,4-methylenedioxyphenyl)propan-1-one (bk-MDDMA) , a β-keto derivative of 3,4-methylenedioxyamphetamine (MDA) by reacting with 2-bromo-3′,4′-methylenedioxypropiophenone. It may also be used to synthesize organic intermediates such as dimethyl-(4-nitro-benzyl)-amine, dimethyl-(4-methyl-benzyl)-amine and 4-dimethylamino-but-2-enoic acid [4-(3,4-dichloro-6-fluoro-phenylamino)-quinazolin-6-yl]-amide.
signalword
Danger
target_organs
Central nervous system, Respiratory system
Classe de stockage
3 - Flammable liquids
flash_point_f
-32.8 °F - closed cup
flash_point_c
-36 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves
Hazard Classifications
Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3
supp_hazards
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Discrimination and identification of regioisomeric ?-keto analogues of 3, 4-methylenedioxyamphetamines by gas chromatography-mass spectrometry.
Zaitsu K, et al.
Forensic Toxicology, 26(2), 45-51 (2008)
[11C]-dimethylamine as a labeling agent for PET biomarkers.
Jacobson O & Mishani E.
Applied Radiation and Isotopes, 66(2), 188-193 (2008)
L Lee et al.
Cancer research, 41(10), 3992-3994 (1981-10-01)
Using a method for nitrosamine analysis that gives high recovery values and that is free from artifactual synthesis of nitrosamines, we have shown that human feces do not contain volatile nitrosamines (detection limit, 0.1 to 0.5 microgram/kg). We also showed



